N-PEP-12 (MemoProve)
Jump to navigation
Jump to search
Indications
- Alzheimer's disease (allegedly approved in 30 countries)
Dosage
may be taken orally
Mechanism of action
- derived from cerebrolysin, but less potent
Clinical trials
- may be effective[1]
More general terms
Components
- pentostatin (Nipent, DCF, 2'deoxycoformycin)
- cyclophosphamide (Cytoxan, Neosar, Procytox {Canadian}) [CPM, CTX, CYT, NSC 26271]
- rituximab (Rituxan, Mabthera, Truxima, Ruxience, Riabni)
References
- ↑ 1.0 1.1 Crook TH et al, Effects of N-PEP-12 on memory among older adults In Clin Psychoparmacol 2005, 20:97 PMID: https://www.ncbi.nlm.nih.gov/pubmed/15729085